1) Vasoconstrictor
[英][,væsəukən'striktə] [美][,væsokən'strɪktɚ]
缩血管活性物质
1.
Object To find the role of ROS in increased paracrine of hypertrophic cardiomyocytes induced by the vasoconstrictors including ET-1 ,AngⅡ.
目的:探讨氧活性产物(reactive oxygen species,ROS)在血管紧张素Ⅱ(AngⅡ),内皮素-1(ET-1)等缩血管活性物质在致心肌细胞肥大时同时促进心肌细胞分泌内皮素中所起的作用。
2) Vasoactive substance
血管活性物质
1.
Study on the role of vasoactive substances in the pathogenesis of hypertension in patients with sleep apnea syndrome;
血管活性物质在睡眠呼吸暂停综合征合并高血压中作用的研究
2.
Effect of sleep-apnea syndrome on vasoactive substances;
睡眠呼吸暂停低通气综合征患者血管活性物质的变化
3.
The effects of nCPAP on blood pressure and vasoactive substances in patients with SAS;
nCPAP治疗SAS的效果及对血压和血管活性物质的影响
3) Vasoactive substances
血管活性物质
1.
Effects of soy oligosaccharides and peptides on vasoactive substances and hemorheology in hyperlipidemia rats;
大豆低聚糖和低聚肽对高脂血症大鼠血管活性物质和血液流变学的影响
2.
Changes of vasoactive substances originated endothelium on patients with unstable angina pectoris treated by low dose of urokinase;
不稳定型心绞痛患者应用小剂量尿激酶前后内皮源性血管活性物质的变化(英文)
3.
Objective To observe the influence of preventive treatment by regulating the function of liver and kidney and removing sputum and blood stasis therapy (RR-Therapy) on the development of SHR hypertension and several vasoactive substances.
目的 探讨调肝肾、祛痰瘀治法方药提前干预对自发性高血压大鼠(SHR)的高血压发展以及对多种血管活性物质的作用。
4) vaso-active substance
血管活性物质
1.
Vaso-active substances including nitric oxide(NO) and endothelin(ET) were measured.
方法 :选择无心血管疾病的SAS患者和正常对照组各 30例进行多导睡眠图 (PSG)、2 4h动态血压 (ABPM )及血管活性物质一氧化氮 (NO)和内皮素 (ET)的监测。
2.
The methods of treating EH with Chinese medicine are mainly from following links:to change hemodynamics and hemorheology mechanisms;to affect RAS;to adjust vaso-active substance;to control the function of cell membranes\' calcium channel and to resist IR.
中医药治疗高血压的途径主要从一下几个环节入手:改变血流动力学和血液流变学机制、对肾素—血管紧张素系统的影响、调节血管活性物质、调控细胞膜钙通道的机能以及抑制胰岛素抵抗等。
6) blood vessel active substances
血管活性物质
1.
A development observation of blood vessel active substances on acute pulmonary embolism caused by echinococus granulous cyst;
细粒棘球蚴内容物致肺栓塞血管活性物质动态观察
补充资料：表面活性物质
表面活性物质
又称"表面活性剂"。能降低溶液表面张力的物质。分布在肺泡的表面，现已知肺的表面活性物质是一种复杂的脂蛋白。其主要成分是二棕榈酰磷脂酰胆碱，它由肺泡Ⅱ型细胞所分泌，以单分子层辅盖在肺泡的内表面，肺泡表面张力与磷脂的浓度成反比例关系，吸气时肺泡扩大，表面活性物质分子间距增加，其浓度相应减少，呼气时肺泡缩小，其浓度增加，使肺泡不致萎缩。并可维持各种大小不一的肺泡容量的稳定性。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条